Literature DB >> 33242176

Impact of age on postsurgical outcomes of nonfunctioning pituitary adenomas.

E Biamonte1,2, N Betella1, D Milani3, G B Lasio3, S Ariano1,2, S Radice3, E Lavezzi1, G Mazziotti4,5, A Lania1,2.   

Abstract

PURPOSE: The management of pituitary adenomas in the elderly has become a relevant clinical issue, in relationship with improved life expectancy and spreading use of imaging techniques. In this single-center and retrospective study, we investigated the impact of age on peri- and postsurgical outcomes in patients undergoing transnasal sphenoidal (TNS) surgery for pituitary adenomas.
METHODS: One-hundred-sixty-nine patients (62% males) undergoing endoscopic transphenoidal (TNS) surgery for nonfunctioning pituitary adenomas (NFPAs) were enrolled. Patients were subdivided into three groups according to age tertiles: ≤56 (group 1), 57-69 (group 2), and ≥70 (group 3) years. Postsurgical and endocrinological outcomes were evaluated and compared among the three age groups.
RESULTS: 37/169 patients (21.9%) developed at least one perisurgical complication, without significant association with the patients' age (P = 0.838), Charlson co-morbidity score (P = 0.326), and American Society of Anesthesiologist score (P = 0.616). In the multivariate regression analysis, the adenoma size resulted the only determinant of perisurgical complication (odds ratio [OR] 1.07, 95% confidence interval [C.I.] 1.00-1.13; P = 0.044). The development and the recovery of at least one pituitary hormone deficiency were observed in 12.2% and 14.2% of patients, respectively. The risk of developing new pituitary hormone deficiencies was correlated with cavernous sinus invasion as evaluated by magnetic resonance imaging (hazard ratio [HR] 4.19, 95% C.I. 1.39-12.66; P = 0.010), whereas the probability to normalize at least one pituitary hormone deficiency was significantly correlated with younger age of patients (HR 0.27, 95% CI 0.12-0.61; P = 0.002).
CONCLUSIONS: The results of this study reinforce the concept that endoscopic TNS surgery is a safe therapeutic option in the elderly patients with NFPA, even in presence of comorbidities and high anesthetic risk.

Entities:  

Keywords:  Adenoma; Age; Complications; Pituitary; Surgery

Year:  2020        PMID: 33242176     DOI: 10.1007/s12020-020-02554-4

Source DB:  PubMed          Journal:  Endocrine        ISSN: 1355-008X            Impact factor:   3.633


  37 in total

Review 1.  The pathogenesis of pituitary tumours.

Authors:  Sylvia L Asa; Shereen Ezzat
Journal:  Nat Rev Cancer       Date:  2002-11       Impact factor: 60.716

2.  The presentation and management of pituitary tumours in the elderly.

Authors:  D L Cohen; J S Bevan; C B Adams
Journal:  Age Ageing       Date:  1989-07       Impact factor: 10.668

3.  Comparison of Pituitary Adenomas in Elderly and Younger Adults: Clinical Characteristics, Surgical Outcomes, and Prognosis.

Authors:  Junfeng Liu; Chaoxi Li; Qungen Xiao; Chao Gan; Xi Chen; Wei Sun; Xiaopeng Li; Yu Xu; Juan Chen; Kai Shu; Ting Lei
Journal:  J Am Geriatr Soc       Date:  2015-08-27       Impact factor: 5.562

Review 4.  Endoscopic endonasal transsphenoidal surgery in elderly patients with pituitary adenomas.

Authors:  Jackson A Gondim; João Paulo Almeida; Lucas Alverne F de Albuquerque; Erika Gomes; Michele Schops; Jose Italo Mota
Journal:  J Neurosurg       Date:  2015-04-03       Impact factor: 5.115

Review 5.  Diagnosis and management of pituitary tumours in the elderly: a review based on personal experience and evidence of literature.

Authors:  Giuseppe Minniti; Vincenzo Esposito; Manolo Piccirilli; Amato Fratticci; Antonio Santoro; Marie-Lise Jaffrain-Rea
Journal:  Eur J Endocrinol       Date:  2005-12       Impact factor: 6.664

Review 6.  CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2011-2015.

Authors:  Quinn T Ostrom; Haley Gittleman; Gabrielle Truitt; Alexander Boscia; Carol Kruchko; Jill S Barnholtz-Sloan
Journal:  Neuro Oncol       Date:  2018-10-01       Impact factor: 12.300

7.  Surgery: Risks of pituitary surgery in the elderly.

Authors:  Pamela U Freda; Jeffrey N Bruce
Journal:  Nat Rev Endocrinol       Date:  2010-11       Impact factor: 43.330

8.  Clinical analysis of 103 elderly patients with pituitary adenomas: transsphenoidal surgery and follow-up.

Authors:  Jingfang Hong; Xuehua Ding; Yicheng Lu
Journal:  J Clin Neurosci       Date:  2008-08-06       Impact factor: 1.961

9.  Transsphenoidal surgical treatment of pituitary adenomas in patients aged 80 years or older.

Authors:  Shunji Yunoue; Hiroshi Tokimura; Atsushi Tominaga; Shingo Fujio; Prasanna Karki; Satoshi Usui; Yasuyuki Kinoshita; Mika Habu; F M Moinuddin; Hirofumi Hirano; Kazunori Arita
Journal:  Neurosurg Rev       Date:  2013-11-15       Impact factor: 3.042

10.  Transsphenoidal pituitary surgery in the elderly is safe and effective.

Authors:  Erlick A C Pereira; Puneet Plaha; Aswin Chari; Menaka Paranathala; Nicholas Haslam; Angela Rogers; Tim Korevaar; Diane Tran; Remi Olarinde; Niki Karavitaki; Ashley B Grossman; Simon A Cudlip
Journal:  Br J Neurosurg       Date:  2013-12-30       Impact factor: 1.596

View more
  3 in total

1.  Endoscopic vs. microscopic transsphenoidal surgery outcomes in 514 nonfunctioning pituitary adenoma cases.

Authors:  Shuaihua Song; Linping Wang; Qianjin Qi; Haoran Wang; Li Feng
Journal:  Neurosurg Rev       Date:  2022-03-01       Impact factor: 3.042

2.  Change in cephalocaudal tumor cavity diameter after transsphenoidal surgery is a predictor of diabetes insipidus in pituitary adenoma.

Authors:  Kunzhe Lin; Kaichun Fan; Shuwen Mu; Shousen Wang
Journal:  Eur J Med Res       Date:  2022-05-25       Impact factor: 4.981

3.  Diaphragma sellae sinking can predict the onset of hyponatremia after transsphenoidal surgery for pituitary adenomas.

Authors:  Kunzhe Lin; Jun Li; Lingling Lu; Shangming Zhang; Shuwen Mu; Zhijie Pei; Cheng Wang; Jingying Lin; Liang Xue; Liangfeng Wei; Lin Zhao; Shousen Wang
Journal:  J Endocrinol Invest       Date:  2021-06-14       Impact factor: 4.256

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.